Dentsply Sirona (XRAY) Common Equity (2009 - 2026)

Dentsply Sirona's Common Equity history runs 18 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• Quarterly Common Equity fell 34.38% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (down 34.38% YoY) and the FY2025 annual result came in at $1.3 billion, down 31.09% from the prior year.
• Common Equity was $1.3 billion for Q1 2026 at Dentsply Sirona, down from $1.3 billion in the prior quarter.
• Across five years, Common Equity topped out at $4.9 billion in Q1 2022 and bottomed at $1.3 billion in Q1 2026.
• A 5-year average of $2.9 billion and a median of $3.3 billion in 2024 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity slipped 0.53% — and 2024, when it plunged 41.01%.
• Dentsply Sirona's Common Equity stood at $3.8 billion in 2022, then retreated by 13.59% to $3.3 billion in 2023, then tumbled by 41.01% to $1.9 billion in 2024, then plunged by 31.09% to $1.3 billion in 2025, then decreased by 1.49% to $1.3 billion in 2026.
• Business Quant data shows XRAY's Common Equity at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.5 billion in Q3 2025.